Información del producto
GSK-3368715 is an experimental drug that is being used to treat cancer. It has shown strong activity against both solid tumours and leukaemia in animal models. GSK-3368715 inhibits the growth of cancer cells by altering the antigen concentration on the surface of the cell, which triggers a response from the immune system. It also inhibits protein methylation and leads to a decrease in arginine methylation, which may be important for treating Alzheimer's disease and other neurological disorders. The molecule has been shown to inhibit cell growth in experimental studies.
Propiedades químicas
Consulta técnica sobre: 3D-EQC01322 GSK-3368715
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
